Literature DB >> 27689306

Tobacco 21: An Important Public Policy to Protect Our Youth.

Harold J Farber1, Smita Pakhale2, Enid R Neptune3.   

Abstract

An important approach to reduce youth tobacco use is the adoption of regulations to prohibit tobacco product sale to individuals younger than 21 years, termed Tobacco 21. In the United States, close to 90% of current smokers started smoking before the age of 18 years, and 99% before age 26 years. Earlier age of tobacco use initiation is associated with lower rates of smoking cessation. Increasing minimum age to purchase has been shown to reduce tobacco product use among youth. The critical determinant is likely the loss of social sources of tobacco products. Enforcement activities are important for age-of-purchase laws to be effective. Raising the minimum legal age to purchase tobacco products to 21 years is highly supported among both the smoking and nonsmoking public. Tobacco sales to those younger than 21 years account for just 2% of total tobacco sales, yet produce 90% of new smokers. The short-term effect on small business of raising the minimum age to purchase would be minimal. Small businesses will have time to adapt to the decrease in tobacco sales as fewer youth grow up nicotine addicted. Raising the minimum age to purchase of tobacco and nicotine products to 21 years, combined with enforcement of those restrictions, will help protect future generations from a lifetime of tobacco dependence and associated morbidity. These regulations should apply to all tobacco products, including electronic nicotine delivery systems. Respiratory health care providers should educate their local, state, and federal policy makers on the importance of Tobacco 21.

Entities:  

Keywords:  prevention and control; public policy; smoking; tobacco use

Mesh:

Year:  2016        PMID: 27689306     DOI: 10.1513/AnnalsATS.201604-253AR

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  7 in total

1.  E-cigarettes: How can they help smokers quit without addicting a new generation?

Authors:  David L Ashley; Claire Adams Spears; Scott R Weaver; Jidong Huang; Michael P Eriksen
Journal:  Prev Med       Date:  2020-05-27       Impact factor: 4.018

2.  A Rapid Evaluation of the US Federal Tobacco 21 (T21) Law and Lessons From Statewide T21 Policies: Findings From Population-Level Surveys.

Authors:  Israel T Agaku; Lungile Nkosi; Queen D Agaku; Joy Gwar; Tina Tsafa
Journal:  Prev Chronic Dis       Date:  2022-06-02       Impact factor: 4.354

3.  Adolescent Susceptibility to E-Cigarettes: An Update From the 2018 National Youth Tobacco Survey.

Authors:  Alayna P Tackett; Brittney Keller-Hamilton; Emily T Hébert; Caitlin E Smith; Samantha W Wallace; Elise M Stevens; Amanda L Johnson; Theodore L Wagener
Journal:  Am J Health Promot       Date:  2020-11-10

4.  California's tobacco 21 minimum sales age law and adolescents' tobacco and nicotine use: differential associations among racial and ethnic groups.

Authors:  Joel W Grube; Sharon Lipperman-Kreda; Grisel García-Ramírez; Mallie J Paschall; Melissa H Abadi
Journal:  Tob Control       Date:  2021-06-30       Impact factor: 7.552

5.  Efficacy of a group-based brief tobacco intervention among young adults aged 18-20 years in the US Air Force.

Authors:  Melissa A Little; Xin-Qun Wang; Margaret C Fahey; Kara P Wiseman; Kinsey Pebley; Robert C Klesges; Gerald W Talcott
Journal:  Tob Induc Dis       Date:  2021-12-08       Impact factor: 2.600

6.  "If You Are Old Enough to Die for Your Country, You Should Be Able to Get a Pinch of Snuff": Views of Tobacco 21 Among Appalachian Youth.

Authors:  Lindsay K Tompkins; Clara G Sears; Joy L Hart; Kandi L Walker; Alexander S Lee; Aruni Bhatnagar
Journal:  J Appl Res Child       Date:  2017

7.  Policy and Behavior: Comparisons between Twitter Discussions about the US Tobacco 21 Law and Other Age-Related Behaviors.

Authors:  Page D Dobbs; Jason B Colditz; Shelby Shields; Anna Meadows; Brian A Primack
Journal:  Int J Environ Res Public Health       Date:  2022-02-24       Impact factor: 4.614

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.